Literature DB >> 17234342

Differential involvement of cyclase- versus non-cyclase-coupled D1-like dopamine receptors in orofacial movement topography in mice: studies with SKF 83822.

Yasuyuki Makihara1, Yaeko Okuda, Chieko Kawada, Mitsuhiko Matsumoto, John L Waddington, Noriaki Koshikawa, Katsunori Tomiyama.   

Abstract

Though orofacial movements are fundamental motor patterns that are known to be regulated critically by D1-like dopamine receptors, these processes remain poorly understood. This uncertainty is heightened by evidence for putative D1-like receptors that are linked not only to adenylyl cyclase (AC) but also to phospholipase C (PLC). Using a new method, we have characterised four topographies of orofacial movement in the mouse using the novel D1-like agonist SKF 83822, which stimulates AC but not PLC. These were compared with responses to SKF 83959, which stimulates PLC but not AC. Also, effects were characterised using the D1-like antagonist SCH 23390 and the D2-like antagonist YM 09151-2. SKF 83822 induced vertical jaw movements with incisor chattering but inhibited horizontal jaw movements; there was little effect on tongue protrusions. Vertical jaw movements induced by SKF 83822 were inhibited by SCH 23390 but uninfluenced by YM 09151-2, while YM 09151-2 released horizontal jaw movements; thus, D1-like agonist-induced, AC-mediated vertical jaw movements constitute a 'pure' D1-like-dependent process that does not involve D1-like:D2-like interactions, while horizontal jaw movements involve oppositional interactions. Orofacial movements in mice appear to consist of at least four phenomenologically dissociable topographies that are mechanistically distinct. They are regulated differentially by AC- and/or PLC-dependent processes and these processes involve distinct D1-like:D2-like interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17234342     DOI: 10.1016/j.neulet.2006.12.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity.

Authors:  Xing Fang; Lin Guo; Jia Jia; Guo-zhang Jin; Bin Zhao; Yong-yong Zheng; Jian-qi Li; Ao Zhang; Xue-chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

3.  Task-Dependent Effects of SKF83959 on Operant Behaviors Associated With Distinct Changes of CaMKII Signaling in Striatal Subareas.

Authors:  Pei-Pei Liu; Chih-Chang Chao; Ruey-Ming Liao
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.